Posted in Regulatory FDA clears first genetic hearing loss gene therapy April 24, 2026 Pharmaphorum Regeneron’s Otarmeni is the first gene therapy for congenital hearing loss to be cleared by the FDA, and will be made available for free in the US. RegulatoryGene TherapyRead full story